Agonist | Subtype | Other name(s) | Affinity | Structure |
5-HT |
non specific |
5-Hydroxytryptamine, Serotonin; Indol-5-ol3-(b-Aminoethyl)-5-hydroxyindole3-(2- aminoethyl)indol-5-ol 5-HTA; 5-Hydroxy-3-(b-aminoethyl)indole; Antemovis; Enteramin; Substance DS; ThrombocytinThrombotonin |
EC50 = 2.2m M (N1E-115 cells) |
|
2-Me-5-HT | 5-HT3 | 2-methyl-5-HT;
2-Methyl-5-hydroxytryptamine; 2-Methylserotonin; |
IC50 = 0.04-0.8 m M
EC50 = 9.9m M |
|
5-CT | 5-HT2A
novel? |
5-Carboxamidotryptamine
|
||
Benzoxazole | 5-HT3
partial agonist/ antagonist |
1-Oxa-3-aza-1H-indene;
1-Oxa-3-azaindene |
||
mCPBG | 5-HT3 | m-Chlorophenylbiguanide ;
Biguanide |
EC50 = 0.76m M | |
Isatin | 5-HT3 | Indole-2,3-dione (8CI);
2,3-Dihydro-1H-indole-2,3-dione; 2,3-Diketoindoline; 2,3-Dioxo-2,3-dihydroindole; 2,3-Dioxoindoline; 2,3-Indolinedione; Isatic acid lactam; Isatinic acid anhydride; o-Aminobenzoylformic anhydride; Pseudoisatin |
antagonist for APN (atrial natriuretic peptide receptor) | |
Neostigmine | AChE antagonist | Ammonium, (m-hydroxyphenyl)-trimethyl-,
dimethylcarbamate (ester) (8CI);
Eustigmin; Prostigmin; Prostigmine; Vagostigmine; m-rimethylammonium-phenyl-dimethylcarbamate |
acetylcholine esterase inhibition potentiates 5-HT3 agonist activity | |
Phenyl-biguanide (PBG) | 5-HT3 | Biguanide-1-phenyl- (6CI, 7CI,
8CI);
1-Phenylbiguanide; N-Phenyl-N'-guanylguanidine; N-Phenylbiguanide; N1-Phenylbiguanide |
EC50 = 22m M | |
Piperazine derivatives (heterocyclic) | 5-HT3 | 1,4-Diazacyclohexane;
1,4-Piperazine; Antiren; Diethylenediamine; Dispermine; Eraverm; Hexahydropyrazine; Lumbrical; Piperazidine; Pipersol; Pyrazine hexahydride; Uvilon; Vermex; Worm-A-Ton; Wurmirazin |
||
Quipazine | 5-HT3 | Quinoline, 2-(1-piperazinyl) | KD = 0.62nM | |
S 21007 | 5-HT3
partial |
Pyrrolo[1,2-a]thieno[3,2-e]pyrazine, 5-[4-(phenylm ethyl)-1-piperazinyl]- (9CI) | EC50 = 27m M
IC50 = 2.8nM |
|
SR 57227A | 5-HT3 | CM 57277 | EC50 = 0.2-11m M |